Digital
genome is one of the emerging technologies in DNA sequencing, which
allows to perform human genome to be sequenced and digitized in
minutes and at the cost of only a few hundred dollars. This is
specifically more efficient than the first sequencing of the 3.2
billion base pairs of a DNA that make up the human genome, which took
many years and cost millions of dollars to completely sequenced. Such
continuous advancement in the field of digital genome enables to
deliver rapid and cost-effective DNA sequencing for development of
personalized medicine and clinical treatment.
The
Global Digital Genome Market is estimated to be valued at US$ 7,594.8
million in 2018, and is expected to witness a CAGR of 10.9% during
the forecast period (2018–2026).
Ask
for In-depth Sample Copy of This Research @
https://www.coherentmarketinsights.com/insight/request-sample/136
Increasing
Technological Advancement in Digital Genome field is expected to
augment the Market Growth
Increasing
technological advancements and growing awareness related to use of
genomes for diagnosis of diseases such as cancer, diabetes, and
Attention Deficit Hyperactivity Disorder (ADHD) are expected to drive
growth of the digital genome market. For instance, in February 2018,
the National Human Genome Research Institute (NHGRI) launched a
strategic planning, which will establish a 2020, vision for genomics
research aimed at accelerating scientific and medical breakthroughs.
Furthermore, in the development of this strategic planning, the
institute will engage experts and diverse public communities to
identify diverse areas of genomics, which will expand the novel
applications in human health and disease treatments.
Increasing
Adoption of Personalized Medicine is expected to propel the Market
Growth
Increasing
inclination towards using genome to predict reaction of medication
for safe and effective treatment of cancer, Attention Deficit
Hyperactivity Disorder (ADHD), diabetes for personalized and safe
treatment to choose most appropriate treatment for ADHD, and
nutrition profiling where DNA is used to prevent development of
chronic diseases are expected to be major growth drivers for the
digital genome market.
Digital
Genome Market - Key Players
Key
players operating in the global digital genome market include,
Illumina, Inc., PerkinElmer, Inc., Pacific Biosciences of California,
Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies
Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC,
Amazon.com, Inc., Deep Genomics, Deep Genomics, Deep Genomics,
Desktop Genetics Ltd., and Ancestry.com LLC.
Detailed
Segmentation:
Global
Digital Genome Market, By Product Type:
-
Sequencer & Analyzers
-
Reagents & Kits
-
Sequencing & Analysis Software
Global
Digital Genome Market, By Application:
-
Clinical
-
Reproductive Health
-
Oncology
-
Others
-
Forensics
-
Drug Discovery and Development
-
Other Applications
Find
the comprehensive research report here with a single click:
https://www.coherentmarketinsights.com/market-insight/digital-genome-market-136
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment